epigallocatechin gallate has been researched along with Memory Disorders in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (10.53) | 29.6817 |
2010's | 14 (73.68) | 24.3611 |
2020's | 3 (15.79) | 2.80 |
Authors | Studies |
---|---|
Auladell, C; Beas-Zarate, C; Busquets, O; Camins, A; Cano, A; Castro-Torres, RD; Ettcheto, M; Folch, J; García, ML; Manzine, PR; Olloquequi, J; Verdaguer, E | 1 |
Allahtavakoli, M; Fatemi, I; Hassanshahi, J; Kaeidi, A; Rahmani, M; Saffar, S; Sahamsizadeh, A; Sheibani, V | 1 |
Fan, J; Nan, S; Wang, P; Zhang, Y | 1 |
Chen, Y; Guo, Y; Nan, Y; Wang, S; Wang, X; Zhao, Y | 1 |
Fan, R; Gao, Y; Liu, X; Mi, Y; Qi, G; Qiao, Q; Sun, Y | 1 |
Aoyama, B; Kawano, T; Locatelli, FM; Nishigaki, A; Shigematsu-Locatelli, M; Tateiwa, H; Yamanaka, D; Yokoyama, M | 1 |
Albericio, G; Borralleras, C; Bosch-Morató, M; Campuzano, V; Guivernau, B; Muñoz, FJ; Ortiz-Romero, P; Pérez-Jurado, LA | 1 |
Aggarwal, R; Chakrabarti, A; Kaur, H; Kumar, B; Medhi, B; Modi, M; Radotra, BD; Sinha, VR | 1 |
Ding, L; Gao, X; Hu, J; Yu, S | 1 |
Andrade, JP; Assunção, M; Cardoso, A; Carvalho, F; Lukoyanov, N; Rodrigues, J | 1 |
Cao, YP; Han, K; Jia, N; Kong, JJ; Ren, GR; Sha, S; Zhang, XM | 1 |
Chen, F; He, M; Liu, H; Liu, M; Sha, L; Sha, X; Tao, L; Wang, S; Wei, M; Yao, L; Yao, Z; Zhang, Z; Zheng, Z; Zhu, Z | 1 |
Chang, KC; Fang, HW; Soung, HS; Tseng, HC; Wang, MH | 1 |
Chang, KC; Chen, CN; Lin, RF; Shih, RL; Soung, HS; Tsai, CC; Tseng, HC; Wang, MH | 1 |
Ha, TY; Hong, JT; Lee, JW; Lee, SY; Lee, YK; Oh, KW; Yuk, DY; Yun, YP | 1 |
Kumar, A; Kumar, P | 1 |
Baluchnejadmojarad, T; Roghani, M | 1 |
Choi, DY; Han, SB; Hong, JT; Lee, YJ; Oh, KW; Yun, YP | 1 |
Chang, KC; Chang, WJ; Soung, HS; Wang, MH | 1 |
19 other study(ies) available for epigallocatechin gallate and Memory Disorders
Article | Year |
---|---|
Epigallocatechin-3-Gallate (EGCG) Improves Cognitive Deficits Aggravated by an Obesogenic Diet Through Modulation of Unfolded Protein Response in APPswe/PS1dE9 Mice.
Topics: Amyloid beta-Peptides; Animals; Blood Glucose; Catechin; Cognitive Dysfunction; Diet, High-Fat; Hippocampus; Insulin; Liver; Male; Memory Disorders; Mice, Inbred C57BL; Mice, Obese; Mice, Transgenic; Models, Biological; Presenilin-1; Signal Transduction; Spatial Learning; Tissue Distribution; Unfolded Protein Response | 2020 |
The effect of epigallocatechin-3-gallate on morphine-induced memory impairments in rat: EGCG effects on morphine neurotoxicity.
Topics: Animals; Apoptosis; Catechin; Glutathione Peroxidase; Hippocampus; Male; Malondialdehyde; Maze Learning; Memory; Memory Disorders; Morphine; Neuroprotective Agents; Neurotoxicity Syndromes; Oxidative Stress; Rats, Wistar; Superoxide Dismutase | 2020 |
Epigallocatechin-3-Gallate Provides Protection Against Alzheimer's Disease-Induced Learning and Memory Impairments in Rats.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Antioxidants; Aspartic Acid Endopeptidases; Catechin; Cognition Disorders; Dose-Response Relationship, Drug; Hippocampus; Male; Maze Learning; Memory Disorders; Neuroprotective Agents; Peptide Fragments; Rats; Rats, Sprague-Dawley; Spatial Memory; tau Proteins | 2021 |
(-)-Epigallocatechin-3-gallate ameliorates memory impairment and rescues the abnormal synaptic protein levels in the frontal cortex and hippocampus in a mouse model of Alzheimer's disease.
Topics: Administration, Oral; Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Catechin; Disease Models, Animal; Disks Large Homolog 4 Protein; Frontal Lobe; Hippocampus; Maze Learning; Memory Disorders; Mice; Motor Activity; Neuroprotective Agents; Nootropic Agents; Peptide Fragments; Phosphorylation; Random Allocation; Spatial Memory; Synaptophysin; tau Proteins | 2017 |
EGCG ameliorates high-fat- and high-fructose-induced cognitive defects by regulating the IRS/AKT and ERK/CREB/BDNF signaling pathways in the CNS.
Topics: Animals; Brain-Derived Neurotrophic Factor; Catechin; Cell Line; Cyclic AMP Response Element-Binding Protein; Dietary Carbohydrates; Dietary Fats; Extracellular Signal-Regulated MAP Kinases; Fructose; Insulin Receptor Substrate Proteins; Learning Disabilities; MAP Kinase Signaling System; Memory Disorders; Mice; Proto-Oncogene Proteins c-akt | 2017 |
Effects of epigallocatechin-3-gallate on systemic inflammation-induced cognitive dysfunction in aged rats.
Topics: Animals; Aspartate Aminotransferases; Catechin; Cognitive Dysfunction; Cytokines; Hippocampus; Inflammation; Lipopolysaccharides; Male; Memory Disorders; Microglia; Rats; Rats, Sprague-Dawley; Sepsis | 2017 |
Epigallocatechin-3-gallate improves cardiac hypertrophy and short-term memory deficits in a Williams-Beuren syndrome mouse model.
Topics: Animals; Cardiomegaly; Catechin; Disease Models, Animal; Memory Disorders; Memory, Short-Term; Mice; Mice, Mutant Strains; Williams Syndrome | 2018 |
A New Therapeutic Approach for Brain Delivery of Epigallocatechin Gallate: Development and Characterization Studies.
Topics: Animals; Behavior, Animal; Biological Availability; Blood-Brain Barrier; Catechin; Cerebral Infarction; Disease Models, Animal; Drug Compounding; Drug Liberation; Emulsions; Humans; Lipids; Male; Memory Disorders; Mice; Nanoparticles; Neuroprotective Agents; Treatment Outcome | 2019 |
(‑)Epigallocatechin‑3‑gallate attenuates anesthesia‑induced memory deficit in young mice via modulation of nitric oxide expression.
Topics: Anesthesia; Animals; Antioxidants; Apoptosis; Arginine; Biomarkers; Catechin; Disease Models, Animal; Indazoles; Male; Memory; Memory Disorders; Mice; Neuroprotective Agents; Nitric Oxide; Nitric Oxide Synthase Type I; Oxidative Stress | 2018 |
Protective effects of a catechin-rich extract on the hippocampal formation and spatial memory in aging rats.
Topics: Age Factors; Animals; Catechin; Dendrites; Disease Models, Animal; Hippocampus; Lysosomes; Male; Malondialdehyde; Maze Learning; Memory Disorders; Microscopy, Electron, Transmission; Mitochondria; Neuroprotective Agents; Protein Carbonylation; Pyramidal Cells; Random Allocation; Rats; Rats, Wistar; Silver Staining; Space Perception | 2013 |
(-)-Epigallocatechin-3-gallate alleviates spatial memory impairment in APP/PS1 mice by restoring IRS-1 signaling defects in the hippocampus.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Blotting, Western; Catechin; Disease Models, Animal; Female; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hippocampus; Immunohistochemistry; Insulin Receptor Substrate Proteins; JNK Mitogen-Activated Protein Kinases; Maze Learning; Memory Disorders; Mice; Mice, Inbred C57BL; Mice, Transgenic; Peptide Fragments; Phosphorylation; Presenilin-1; Proto-Oncogene Proteins c-akt; Serine; Signal Transduction; Tumor Necrosis Factor-alpha | 2013 |
(-)-Epigallocatechin-3-gallate ameliorates learning and memory deficits by adjusting the balance of TrkA/p75NTR signaling in APP/PS1 transgenic mice.
Topics: Amyloid beta-Protein Precursor; Animals; Avoidance Learning; Catechin; Male; Memory Disorders; Mice; Mice, Transgenic; Presenilin-1; Receptor, trkA; Receptors, Nerve Growth Factor; Signal Transduction | 2014 |
(-)Epigallocatechin-3-gallate decreases the stress-induced impairment of learning and memory in rats.
Topics: Animals; Antioxidants; Catechin; Hippocampus; Learning Disabilities; Male; Maze Learning; Memory Disorders; Motor Activity; Rats, Sprague-Dawley; Reactive Oxygen Species; Restraint, Physical; Spatial Learning; Stress, Psychological; Thiobarbituric Acid Reactive Substances | 2015 |
Nitric oxide pathway activity modulation alters the protective effects of (-)Epigallocatechin-3-gallate on reserpine-induced impairment in rats.
Topics: Animals; Arginine; Catechin; Discrimination, Psychological; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Exploratory Behavior; Glutathione; Hippocampus; Lipid Peroxidation; Male; Memory Disorders; Neuroprotective Agents; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar; Reserpine; Signal Transduction; Smell; Superoxide Dismutase | 2016 |
(-)-Epigallocatechin-3-gallate prevents lipopolysaccharide-induced elevation of beta-amyloid generation and memory deficiency.
Topics: Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Apoptosis; Avoidance Learning; Brain; Catechin; Cerebral Cortex; Cyclooxygenase 2; Glial Fibrillary Acidic Protein; Hippocampus; Lipopolysaccharides; Male; Maze Learning; Memory; Memory Disorders; Mice; Nerve Tissue Proteins; Neurons; Nitric Oxide Synthase Type II; Peptide Fragments | 2009 |
Effect of lycopene and epigallocatechin-3-gallate against 3-nitropropionic acid induced cognitive dysfunction and glutathione depletion in rat: a novel nitric oxide mechanism.
Topics: Animals; Brain; Carotenoids; Catechin; Disease Models, Animal; Glutathione; Huntington Disease; Lycopene; Male; Maze Learning; Memory Disorders; Neuroprotective Agents; Nitric Oxide; Oxidative Stress; Rats | 2009 |
Chronic epigallocatechin-3-gallate ameliorates learning and memory deficits in diabetic rats via modulation of nitric oxide and oxidative stress.
Topics: Animals; Avoidance Learning; Blood Glucose; Body Weight; Catechin; Diabetes Mellitus, Experimental; Hippocampus; Indazoles; Learning Disabilities; Male; Malondialdehyde; Maze Learning; Memory Disorders; Nerve Tissue Proteins; Neuroprotective Agents; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase Type I; Nitrites; Oxidative Stress; Rats; Rats, Wistar | 2011 |
Epigallocatechin-3-gallate prevents systemic inflammation-induced memory deficiency and amyloidogenesis via its anti-neuroinflammatory properties.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Astrocytes; Behavior, Animal; Catechin; Cells, Cultured; Cyclooxygenase 2; Cytokines; Disease Models, Animal; Inflammation; Lipopolysaccharides; Male; Memory Disorders; Mice; Mice, Inbred ICR; Neurons; Nitric Oxide Synthase Type II; Peptide Fragments; Rats | 2013 |
(-)-Epigallocatechin-3-gallate decreases the impairment in learning and memory in spontaneous hypertension rats.
Topics: Animals; Antioxidants; Blood Pressure; Catechin; Hippocampus; Hypertension; Learning Disabilities; Lipid Peroxidation; Male; Maze Learning; Memory Disorders; Motor Activity; Oxidative Stress; Rats; Rats, Inbred SHR; Reactive Oxygen Species; Tea | 2012 |